Experience

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the approximately $128 million follow-on offering by Orchard Therapeutics…

Davis Polk advised the initial purchasers with a $100 million Regulation S only high-yield offering by Power Best Global Investments Limited of its 13.0% senior notes due 2021. The notes…

Davis Polk advised the joint book-running managers in connection with an offering by Flex Ltd. of $450 million aggregate principal amount of its 4.875% notes due 2029.Davis Polk is also…

Davis Polk advised the initial purchasers in connection with a $500 million offering of 5.250% notes due 2029 by Ultrapar International S.A., which were issued pursuant to Rule 144A and…

Davis Polk advised Haitong UniTrust International Leasing Co., Ltd. in connection with its spinoff from Haitong Securities Co., Ltd. (dual listed on the Hong Kong Stock Exchange and the…

Davis Polk advised the initial purchasers in connection with Rule 144A offerings by IAC FinanceCo 2, Inc. and IAC FinanceCo 3, Inc., wholly owned subsidiaries of IAC/InterActiveCorp (“IAC”)…

Davis Polk advised The Metropolis of Tokyo in connection with its $1 billion Rule 144A/Regulation S offering of 2.625% bonds due 2024. The Davis Polk corporate team included partner Jon…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Vista Malta Finance P.L.C. and XO Management Holding, Inc., subsidiaries of Vista…

Davis Polk advised the underwriters in connection with an initial public offering of 5,750,000 shares of common stock of IDEAYA Biosciences, Inc. at $10.00 per share (which includes the…

Davis Polk advised the joint book-running managers in connection with the secondary offering of 15,000,000 shares of common stock of SolarWinds Corporation by certain of SolarWinds’…